Cargando…

Horizon scanning implanted biosensors in personalising breast cancer management: First pilot study of breast cancer patients views

AIMS: This study aimed to explore breast cancer patients' understanding and acceptability of implanted biosensors (BS) within the primary tumour to personalise adjuvant radiotherapy, and to determine optimal design and number of BS, and evaluate potential clinical benefits as well as concerns a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ikegwuonu, Theresa, Haddow, Gill, Tait, Joyce, Murray, Alan F., Kunkler, Ian H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6266376/ https://www.ncbi.nlm.nih.gov/pubmed/30613798 http://dx.doi.org/10.1002/hsr2.30

Ejemplares similares

New Horizons for Personalised Treatment in Gastroesophageal Cancer
por: Salati, Massimiliano, et al.
Publicado: (2022)

Risk assessment, disease prevention and personalised treatments in breast cancer: is clinically qualified integrative approach in the horizon?
por: Golubnitschaja, Olga, et al.
Publicado: (2013)

Human Microbiota and Breast Cancer—Is There Any Relevant Link?—A Literature Review and New Horizons Toward Personalised Medicine
por: Alpuim Costa, Diogo, et al.
Publicado: (2021)

Cyborgs in the Everyday: Masculinity and Biosensing Prostate Cancer
por: Haddow, Gill, et al.
Publicado: (2015)

The Mediterranean Diet and Breast Cancer: A Personalised Approach
por: Shaikh, Amani Al, et al.
Publicado: (2019)

Nomogram for the personalisation of radiotherapy treatments in breast cancer patients
por: Beato Tortajada, Inmaculada, et al.
Publicado: (2021)

UK Women’s Views of the Concepts of Personalised Breast Cancer Risk Assessment and Risk-Stratified Breast Screening: A Qualitative Interview Study
por: Kelley-Jones, Charlotte, et al.
Publicado: (2021)

Established and new horizons in radiotherapy for breast cancer
por: Wu, Trudy C., et al.
Publicado: (2023)

Biosensors: from personalised medicine to population health
Publicado: (2020)

Breast cancer genome heterogeneity: a challenge to personalised medicine?
por: Swanton, Charles, et al.
Publicado: (2011)

Polygenic susceptibility to prostate and breast cancer: implications for personalised screening
por: Pashayan, N, et al.
Publicado: (2011)

Personalising clinical pathways in a London breast cancer service
por: Viney, William, et al.
Publicado: (2022)

Triple-negative breast cancer: is there a treatment on the horizon?
por: Yao, Hui, et al.
Publicado: (2016)

Breast density measurement for personalised screening
por: Sergeant, JC, et al.
Publicado: (2012)

Predictive, Preventive and Personalised Medicine as the hardcore of ‘Horizon 2020’: EPMA position paper
por: Golubnitschaja, Olga, et al.
Publicado: (2014)

Bioengineering horizon scan 2020
por: Kemp, Luke, et al.
Publicado: (2020)

BIA-ALCL-Horizon Scanning
por: Mallucci, Patrick, et al.
Publicado: (2022)

Breast Cancer and Tamoxifen: A Nigerian Perspective to Effective Personalised Therapy
por: Adehin, Ayorinde, et al.
Publicado: (2020)

Automated Breast Ultrasound System for Breast Cancer Evaluation: Diagnostic Performance of the Two-View Scan Technique in Women with Small Breasts
por: Kwon, Bo Ra, et al.
Publicado: (2020)

Modelling Circulating Tumour Cells for Personalised Survival Prediction in Metastatic Breast Cancer
por: Ascolani, Gianluca, et al.
Publicado: (2015)

Personalised Therapies for Metastatic Triple-Negative Breast Cancer: When Target Is Not Everything
por: Capici, Serena, et al.
Publicado: (2022)

Horizon scanning in Brazil: outputs and repercussions
por: Gomes, Pollyanna Teresa Cirilo, et al.
Publicado: (2019)

Use of the Internet in Scanning the Horizon for New and Emerging Health Technologies: A Survey of Agencies Involved in Horizon Scanning
por: Douw, Karla, et al.
Publicado: (2003)

Digital immunohistochemistry: new horizons and practical solutions in breast cancer pathology
por: Laurinavicius, Arvydas, et al.
Publicado: (2013)

Targeting HER2 in breast cancer: new drugs and paradigms on the horizon
por: Tarantino, Paolo, et al.
Publicado: (2021)

Editorial: Advanced imaging in breast cancer: New hopes, new horizons!
por: Mahajan, Abhishek, et al.
Publicado: (2023)

Application of Biosensors in Detecting Breast Cancer Metastasis
por: Deng, Yu, et al.
Publicado: (2023)

Update Breast Cancer 2019 Part 4 – Diagnostic and Therapeutic Challenges of New, Personalised Therapies for Patients with Early Breast Cancer
por: Schütz, Florian, et al.
Publicado: (2019)

Update Breast Cancer 2019 Part 5 – Diagnostic and Therapeutic Challenges of New, Personalised Therapies in Patients with Advanced Breast Cancer
por: Welslau, Manfred, et al.
Publicado: (2019)

Breast Implants and Breast Cancer
por: Mehrabani, Davood, et al.
Publicado: (2012)

Cumulative risk of breast cancer screening outcomes according to the presence of previous benign breast disease and family history of breast cancer: supporting personalised screening
por: Román, M, et al.
Publicado: (2017)

Psychological impact of providing women with personalised 10-year breast cancer risk estimates
por: French, David P., et al.
Publicado: (2018)

Personalising therapy for early-stage oestrogen receptor-positive breast cancer in older women
por: Carleton, Neil, et al.
Publicado: (2022)

BREAst screening Tailored for HEr (BREATHE)—A study protocol on personalised risk-based breast cancer screening programme
por: Liu, Jenny, et al.
Publicado: (2022)

Circulating microRNAs - a new horizon in molecular diagnosis of breast cancer
por: Hagrass, Hoda A., et al.
Publicado: (2015)

Radiomics in Triple Negative Breast Cancer: New Horizons in an Aggressive Subtype of the Disease
por: Mireștean, Camil Ciprian, et al.
Publicado: (2022)

Breast radiology: New horizons in times of pandemics()
por: Pina, L.
Publicado: (2022)

Graphene-Based Electrochemical Biosensors for Breast Cancer Detection
por: Mohammadpour-Haratbar, Ali, et al.
Publicado: (2023)

Hypothesis: can the abscopal effect explain the impact of adjuvant radiotherapy on breast cancer mortality?
por: Jatoi, Ismail, et al.
Publicado: (2018)

Blood-Based mRNA Tests as Emerging Diagnostic Tools for Personalised Medicine in Breast Cancer
por: Čelešnik, Helena, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qh8ilo8td66khuptm52p00gvqv